{"id":"W3094234317","doi":"10.1177/2040620720966137","title":"One-year efficacy and safety of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria naïve to complement inhibitor therapy: open-label extension of a randomized study","year":2020,"lang":"en","type":"article","venue":"Therapeutic Advances in Hematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":37,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"European Hematology Association; Alexion Pharmaceuticals","keywords":"Eculizumab; Paroxysmal nocturnal hemoglobinuria; Medicine; Internal medicine; Immunology; Antibody; Complement system","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006184641,0.0002825956,0.001910987,0.0001639216,0.0000519639,0.000006772244,0.0004467701,0.00008835919,0.0002082847],"category_scores_gemma":[0.0001136766,0.0002220265,0.0000452242,0.0003251108,0.0003692539,0.0001114737,0.0002930858,0.0001978387,0.000007400053],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003745145,"about_ca_system_score_gemma":0.00007678978,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009337511,"about_ca_topic_score_gemma":0.0002290097,"domain_scores_codex":[0.9964893,0.001219322,0.001279844,0.0005465018,0.0001059271,0.000359123],"domain_scores_gemma":[0.9980875,0.000924541,0.0004871769,0.0003452879,0.0001066395,0.00004886483],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8921115,0.004990737,0.05544725,0.0004832559,0.0007690442,0.00002667464,0.01532913,0.000147128,0.01163415,0.004390691,0.00002931694,0.01464112],"study_design_scores_gemma":[0.9446072,0.008724972,0.0197589,0.001596614,0.0001813262,0.00006393109,0.009523218,0.00007882699,0.0129491,0.0009306333,0.0009707226,0.0006145604],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9729367,0.02030195,0.0003149402,0.000560792,0.0001252426,0.005639825,0.00002777962,0.00001993094,0.00007286883],"genre_scores_gemma":[0.998458,0.0004115592,0.0006042612,0.0002280153,0.00001047916,0.0002432816,0.00001822809,0.00002228263,0.000003884279],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0524957,"threshold_uncertainty_score":0.9053978,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03983949947990802,"score_gpt":0.324679299457079,"score_spread":0.284839799977171,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}